当前位置:
X-MOL 学术
›
J. Clin. Invest.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Activation of Gs signaling in mouse enteroendocrine K cells greatly improves obesity- and diabetes-related metabolic deficits
The Journal of Clinical Investigation ( IF 13.3 ) Pub Date : 2024 , DOI: 10.1172/jci182325 Antwi-Boasiako Oteng, Liu Liu, Yinghong Cui, Oksana Gavrilova, Huiyan Lu, Min Chen, Lee S. Weinstein, Jonathan E. Campbell, Jo E. Lewis, Fiona M. Gribble, Frank Reimann, Jürgen Wess
The Journal of Clinical Investigation ( IF 13.3 ) Pub Date : 2024 , DOI: 10.1172/jci182325 Antwi-Boasiako Oteng, Liu Liu, Yinghong Cui, Oksana Gavrilova, Huiyan Lu, Min Chen, Lee S. Weinstein, Jonathan E. Campbell, Jo E. Lewis, Fiona M. Gribble, Frank Reimann, Jürgen Wess
Following a meal, glucagon-like peptide 1 (GLP1) and glucose-dependent insulinotropic polypeptide (GIP), the 2 major incretins promoting insulin release, are secreted from specialized enteroendocrine cells (L and K cells, respectively). Although GIP is the dominant incretin in humans, the detailed molecular mechanisms governing its release remain to be explored. GIP secretion is regulated by the activity of G protein–coupled receptors (GPCRs) expressed by K cells. GPCRs couple to 1 or more specific classes of heterotrimeric G proteins. In the present study, we focused on the potential metabolic roles of K cell Gs. First, we generated a mouse model that allowed us to selectively stimulate K cell Gs signaling. Second, we generated a mouse strain harboring an inactivating mutation of Gnas, the gene encoding the α-subunit of Gs, selectively in K cells. Metabolic phenotyping studies showed that acute or chronic stimulation of K cell Gs signaling greatly improved impaired glucose homeostasis in obese mice and in a mouse model of type 2 diabetes, due to enhanced GIP secretion. In contrast, K cell–specific Gnas-KO mice displayed markedly reduced plasma GIP levels. These data strongly suggest that strategies aimed at enhancing K cell Gs signaling may prove useful for the treatment of diabetes and related metabolic diseases.
中文翻译:
小鼠肠内分泌 K 细胞中 Gs 信号转导的激活极大地改善了肥胖和糖尿病相关的代谢缺陷
饭后,胰高血糖素样肽 1 (GLP1) 和葡萄糖依赖性促胰岛素多肽 (GIP) 是促进胰岛素释放的 2 种主要肠促胰岛素蛋白,由专门的肠内分泌细胞(分别为 L 细胞和 K 细胞)分泌。尽管 GIP 是人类中的主要肠促胰岛素,但控制其释放的详细分子机制仍有待探索。GIP 分泌受 K 细胞表达的 G 蛋白偶联受体 (GPCR) 活性的调节。GPCR 偶联 1 类或多类特异性三聚体 G 蛋白。在本研究中,我们专注于 K 细胞 Gs 的潜在代谢作用。首先,我们生成了一个小鼠模型,该模型使我们能够选择性地刺激 K 细胞 Gs 信号传导。其次,我们在 K 细胞中选择性地生成了一种小鼠品系,该菌株携带 Gnas 的失活突变,Gnas 是编码 Gs α 亚基的基因。代谢表型研究表明,由于 GIP 分泌增强,K 细胞 Gs 信号传导的急性或慢性刺激大大改善了肥胖小鼠和 2 型糖尿病小鼠模型中受损的葡萄糖稳态。相比之下,K 细胞特异性 Gnas-KO 小鼠血浆 GIP 水平显著降低。这些数据强烈表明,旨在增强 K 细胞 Gs 信号转导的策略可能被证明对治疗糖尿病和相关代谢疾病有用。
更新日期:2024-12-17
中文翻译:
小鼠肠内分泌 K 细胞中 Gs 信号转导的激活极大地改善了肥胖和糖尿病相关的代谢缺陷
饭后,胰高血糖素样肽 1 (GLP1) 和葡萄糖依赖性促胰岛素多肽 (GIP) 是促进胰岛素释放的 2 种主要肠促胰岛素蛋白,由专门的肠内分泌细胞(分别为 L 细胞和 K 细胞)分泌。尽管 GIP 是人类中的主要肠促胰岛素,但控制其释放的详细分子机制仍有待探索。GIP 分泌受 K 细胞表达的 G 蛋白偶联受体 (GPCR) 活性的调节。GPCR 偶联 1 类或多类特异性三聚体 G 蛋白。在本研究中,我们专注于 K 细胞 Gs 的潜在代谢作用。首先,我们生成了一个小鼠模型,该模型使我们能够选择性地刺激 K 细胞 Gs 信号传导。其次,我们在 K 细胞中选择性地生成了一种小鼠品系,该菌株携带 Gnas 的失活突变,Gnas 是编码 Gs α 亚基的基因。代谢表型研究表明,由于 GIP 分泌增强,K 细胞 Gs 信号传导的急性或慢性刺激大大改善了肥胖小鼠和 2 型糖尿病小鼠模型中受损的葡萄糖稳态。相比之下,K 细胞特异性 Gnas-KO 小鼠血浆 GIP 水平显著降低。这些数据强烈表明,旨在增强 K 细胞 Gs 信号转导的策略可能被证明对治疗糖尿病和相关代谢疾病有用。